What’s New?
What’s New?
Three Hot Topics from EASD
The European Association for the Study of Diabetes (EASD) conference is a key event where groundbreaking research and advancements in diabetes care are presented. This year, three hot topics stood out: the competition between once-weekly insulins, the ongoing...
Patient engagement in early product development for AML: bringing patient insights to the heart of early clinical strategy
If you're a EPHMRA member and couldn’t attend you can access the conference videos here. If you would like more information get in touch with Ben Walker, Research Director at Adelphi Research - [email protected]. The importance of patient engagement in the...
Three Hot Topics from ADA 2024
Biotech takes on chronic weight management As Novo Nordisk and Lilly generate massive profits with weight-loss blockbusters Wegovy and Zepbound, several smaller players are looking to develop novel solutions that address some of the challenges with currently marketed...
Top News from Biggest Players at ASCO 2024
ASCO 2024 ran from May 31-June 4 in Chicago, IL, bringing together physicians, academics, and industry to share data and discuss cutting edge treatments in oncology. Below, Adelphi’s Oncology Task Force breaks down key news from some of the biggest players in...
Looking for the answer to your business challenge? There isn’t one!
There are many possible answers to a challenge, depending on how you look at the problem. At Adelphi Research, we are firm believers in the value of looking at problems through multiple lenses and utilising different perspectives to uncover truly brilliant solutions....
What Prevents Underrepresented Populations from Participating in Market Research?
Sample diversity is critical to the development of quality market research insights that help improve strategies around patient care. Even with this knowledge, reaching underrepresented populations in pharmaceutical market research is an ongoing challenge. Now that we...
An Exceptional Career Awaits You At Adelphi Research
Adelphi Research is a global market research consultancy that inspires action and drives change. We’ve been providing insights that impact strategic decision-making for pharmaceutical and healthcare organisations for over 30 years. Our services span the development...
Continuing to Drive Change in 2024
As we enter a new year, our end goal remains the same – to inspire action and drive change. We are always on the lookout for ways to enhance the insights we bring to our clients, whether we are using innovative technology with agility, understanding behaviour, or...
Adelphi Attends Trio Of Exciting Conferences
Over the last few months our team has been busy attending a range of interesting conferences to discuss all things innovation and healthcare research. We’ve attended conferences by some of the most interesting voices in the industry, including Intellus, JP Morgan...
Highlights from A&I Summit 2023
Our team here at Adelphi are always busy keeping on top of the latest trends and developments in pharma and healthcare research, and this month has been no different, with Adelphi attending the A&I Summit in Barcelona. The Analytics & Insights Summit was held...
Barriers and Biases in Pharma Research – Part Three. A collaboration with Nick Southgate
In the third article in our series, we start by considering respondents cannot tell us everything. To get to insightful ideas that change behaviour and help clients’ businesses we need to take some more steps. First, we need to ask better questions. We’ll start by...
Adelphi Research is celebrating 33 years in business
Every day, we are inspired to make a difference to patient lives all across the world. From day one, it’s always been important to us to keep evolving and transforming to put forth exceptional results to continue improving the lives of patients. With that, we’ve...
Privacy Policy | Cookie Notice | Data Privacy Framework Policy | California Consumer Privacy | Recruitment Privacy Notice
Copyright © 2020 - 2024 Adelphi Research | Designed by Embrace Marketing Ltd
Company Reg No: 1975338 Registered Office : Bankside3 90-100 Southwark St, London SE1 0SW